Further investigations have shown that Sirt6 directly interacts with Smad3, where it deacetylates Smad3, thereby inhibiting its transcriptional activity and nuclear accumulation, offering protection against renal injury in diabetic kidney disease (52). This evidence concerns the gene SMAD3 and diabetic kidney disease.